Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr3.96 SEK
Change Today -0.10 / -2.46%
Volume 7.5K
GENI On Other Exchanges
As of 11:30 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

generic sweden ab (GENI) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/12/15 - kr4.50
52 Week Low
10/22/14 - kr3.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GENERIC SWEDEN AB (GENI)

Related News

No related news articles were found.

generic sweden ab (GENI) Related Businessweek News

No Related Businessweek News Found

generic sweden ab (GENI) Details

Generic Sweden AB provides consulting and telecommunication services in Sweden. It operates through two divisions, Consultancy and Telecom. The company offers business development, information management, communications and sensor system, and technical systems development consulting services to the defense and public security, as well as to product development organizations within the energy, telecommunications, transport/infrastructure, and medtech sectors. It also provides various telecommunication services, including messaging services based on e-mail, SMS, fixed network SMS, and fax services to emergency service providers, county councils and police, mobile operators, bank and insurance companies, and private security companies, as well as to hospitals and nuclear power stations. Generic Sweden AB was founded in 1993 and is headquartered in Stockholm, Sweden.

Founded in 1993

generic sweden ab (GENI) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: kr1.1M
Compensation as of Fiscal Year 2014.

generic sweden ab (GENI) Key Developments

Generic Sweden AB to Report Q2, 2015 Results on Aug 21, 2015

Generic Sweden AB announced that they will report Q2, 2015 results on Aug 21, 2015

Generic Sweden AB to Report Fiscal Year 2014 Results on Feb 13, 2015

Generic Sweden AB announced that they will report fiscal year 2014 results on Feb 13, 2015

Generic Sweden AB to Report Q1, 2015 Results on May 12, 2015

Generic Sweden AB announced that they will report Q1, 2015 results on May 12, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GENI:SS kr3.96 SEK -0.10

GENI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GENI.
View Industry Companies

Industry Analysis


Industry Average

Valuation GENI Industry Range
Price/Earnings 10.4x
Price/Sales 0.4x
Price/Book 1.2x
Price/Cash Flow 7.4x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENERIC SWEDEN AB, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at